Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company developing next-generation cardiovascular therapeutics, and its clinical development division Sardocor, today announced that the U.S.

GC Biopharma USA, Inc., a leader in plasma-derived products, today announced the presentation of new research evaluating the aggregation profiles, including molecular size distribution and particle ...

Biohackers World Expo Los Angeles 2026 signaled a shift toward practical, measurable biohacking tools that deliver real ...

VentriPoint Diagnostics (TSXV: VPT) (OTCPK: VPTDF) just locked in a new healthcare partnership in Central America. The Toronto-based medtech company announced a collaboration with the Health Division ...

Every year, hundreds of thousands of people in the United Kingdom undergo a cardiac CT scan, usually to check for blocked ...

The expansion of Boston Scientific’s research and development unit in Galway is part of a €75 million investment in new ...